New Blue Phosphorescent Iridium Complexes Containing Phenylpyridine and Triazole Ligands: Synthesis and Luminescence Studies

$113.00 plus tax (Refund Policy)

Buy Article:


The synthesis and luminescence of iridium(III) complexes containing new phenylpyridine (C^N) ligands, 4-Me-4′-F-ppy, 4-Me-4′-CF3-ppy and 4-OMe-4′-CF3-ppy, were studied. These ligands were designed for development of the blue light-emitting iridium complexes by introducing the electron-withdrawing group (F, CF3) and the electron-donating group (Me, OMe) at the para positions of the phenyl and pyridine ligand rings, respectively. As an ancillary ligand, trzl-CMe3 was employed where trzl-CMe3 represents 2-(5-tert′-butyl-2H-1,2,4-triazol-3-yl)pyridine. The resulting iridium complexes, Ir(4-Me-4′-F-ppy)2 (trzl-CMe3), Ir(4-OMe-4′-CF3-ppy)2 (trzl-CMe3) and Ir(4-Me-4′-CF3-ppy)2(trzl-CMe3) exhibited the blue emission at 472, 484 and 494 nm in CH2Cl2 solution, respectively. Ir(4-Me-4′-F-ppy)2(trzl-CMe3) showed the most hypsochromic shift in photoluminescence (PL) among the complexes prepared herein. In the electroluminescence (EL) spectra, Ir(4-Me-4′-F-ppy)2(trzl-CMe3) and Ir(4-Me-4′-CF3-ppy)2(trzl-CMe3) exhibited the luminescence peak at 437 nm and 496 nm, respectively. In the aspect of blue emission color purity, Ir(4-Me-4′-F-ppy)2(trzl-CMe3) had the CIE coordinates of (0.176, 0.143), very close to the saturated standard blue emission.


Document Type: Research Article


Publication date: May 1, 2011

More about this publication?
  • Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • ingentaconnect is not responsible for the content or availability of external websites
Related content



Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more